OCON Therapeutics
PrivateLast Round
VC Round
Jun 24, 2024
Total Funding Raised
$1.7M
Company Overview
OCON Therapeutics is a health tech and life sciences company that develops, manufactures, and commercializes intrauterine drug-delivery technologies for women's health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
IUDintrauterine devicewomen's healthdrug delivery systemcontraceptionmedical devicegynecological treatmentnon-hormonal contraceptionabnormal uterine bleedinglocalized drug deliveryfemtechmedtech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OCON Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
OCON Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 24, 2024 | ||||
| VC Round | Dec 18, 2020 | ||||
| VC Round | Jun 22, 2020 | ||||
| Strategic | Oct 19, 2017 | ||||
| Seed | May 7, 2013 |
OCON Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Exerte Partners | VC Round |
| Israel Innovation Authority | VC Round |
| Features Capital | VC Round |
| Astia Angels | VC Round |
| Pontifax Venture Capital | VC Round, Seed |
| Docor International Management | VC Round, Seed |
| RH Capital | VC Round |
OCON Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OCON Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersIsrael
Employee Range29
Year Founded2011
Last FundingJun 24, 2024